Melanoma in pregnancy - where we are?

被引:1
|
作者
Izycki, Dariusz [1 ]
Kerrigan, Christopher Patrick [2 ]
Kazmierczak, Maciej [3 ]
机构
[1] Poznan Univ Med Sci, Dept Canc Immunol, PL-61866 Poznan, Poland
[2] Poznan Univ Med Sci, PL-61866 Poznan, Poland
[3] Poznan Univ Med Sci, Dept Hematol, PL-61866 Poznan, Poland
来源
PRZEGLAD MENOPAUZALNY | 2013年 / 12卷 / 06期
关键词
melanoma malignum; pregnancy; ORAL-CONTRACEPTIVE USE; MALIGNANT-MELANOMA; METASTATIC MELANOMA; WOMEN; SURVIVAL;
D O I
10.5114/pm.2013.39806
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
With rising rates of melanoma and women bearing children at older ages, the incidence of malignant melanoma in pregnancy will continue to increase. Initial reports in the 1950s portrayed a belief of the medical community that pregnant women who were diagnosed with malignant melanoma suffered a poorer prognosis. Numerous studies since then have shown that this is not the case, and pregnancy has not been shown to have a negative impact on the prognosis of malignant melanoma. Various mechanisms of hormones affecting malignant melanoma have been proposed, although nothing conclusive has been found. And although very rare, fetal metastasis is a serious risk and needs to be kept under consideration. Continual research and period reviews are necessary to best understand any effects of pregnancy on malignant melanoma, guide research, and maximize patient care.
引用
收藏
页码:493 / 495
页数:3
相关论文
共 50 条
  • [1] Melanoma: Where we are and where we go
    Mohammadpour, Ali
    Derakhshan, Maryam
    Darabi, Hassan
    Hedayat, Pegah
    Momeni, Mohammad
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (04) : 3307 - 3320
  • [2] Melanoma etiology: where are we?
    Tucker, MA
    Goldstein, AM
    [J]. ONCOGENE, 2003, 22 (20) : 3042 - 3052
  • [3] Melanoma etiology: where are we?
    Margaret A Tucker
    Alisa M Goldstein
    [J]. Oncogene, 2003, 22 : 3042 - 3052
  • [4] Obesity in pregnancy; Where are we, where should we go?
    Poston, Lucilla
    [J]. MIDWIFERY, 2017, 49 : 4 - 6
  • [5] Neoadjuvant Immunotherapy in Melanoma: Where We Are and Where We Aren't
    Patel, Sapna P.
    [J]. ONCOLOGY-NEW YORK, 2023, 37 (10):
  • [6] Vitamin D in pregnancy: Where we are and where we should go
    Kiely, M. E.
    Wagner, C. L.
    Roth, D. E.
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2020, 201
  • [7] Biomarkers in melanoma: where are we now?
    Johnson, Douglas B.
    Sullivan, Ryan J.
    [J]. MELANOMA MANAGEMENT, 2014, 1 (02) : 139 - 150
  • [8] Monochorionic pregnancy - Where have we been? Where are we going?
    Malone, FD
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (05) : 1308 - 1309
  • [9] Automated melanoma diagnosis: where are we at?
    Day, GR
    Barbour, RH
    [J]. SKIN RESEARCH AND TECHNOLOGY, 2000, 6 (01) : 1 - 5
  • [10] Radiation and Melanoma: Where Are We Now?
    Bliley, Roy
    Avant, Adam
    Medina, Theresa M.
    Lanning, Ryan M.
    [J]. CURRENT ONCOLOGY REPORTS, 2024, 26 (08) : 904 - 914